Clinical Trial Update: XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update for the XeNA study evaluating Xeloda (capecitabine) in invasive breast cancer. The trial is completed and results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED | Results posted: 2011-08-10